Ulisse Biomed has a total shareholder equity of €24.7M and total debt of €434.8K, which brings its debt-to-equity ratio to 1.8%. Its total assets and total liabilities are €28.6M and €3.8M respectively.
Short Term Liabilities: UBM's short term assets (€5.0M) exceed its short term liabilities (€2.1M).
Long Term Liabilities: UBM's short term assets (€5.0M) exceed its long term liabilities (€1.7M).
Debt to Equity History and Analysis
Debt Level: UBM has more cash than its total debt.
Reducing Debt: UBM's debt to equity ratio has increased from 0.1% to 1.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if UBM has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if UBM has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
